Advantage Multi * FREE SHIPPING
* On All Orders
Advantage, Advantix and Advantage Multi are manufactured, distributed and registered trademarks of Bayer Corporation, Germany.
Advantage MultiŽ for Dogs and Cats (imidacloprid + moxidectin) Topical Solution
Advantage Multi for Dogs and Cats combines 100 percent prevention for heartworm disease, as shown in clinical trials, with the flea control of AdvantageŽ. Plus treatment and control of hookworms and roundworms (plus whipworms in dogs) - all in one, convenient, monthly topical solution.
100 percent effective at preventing heartworm disease caused by Dirofilaria immitis, as shown in clinical trials.
100 percent effective treatment and control of hookworm infections caused by Ancylostoma caninum and Uncinaria stenocephala (adults, immature adults and fourth stage larvae).
Up to 98.2 percent effective treatment and control of roundworm infections caused by Toxocara canis (adults and fourth stage larvae).
Up to 100 percent effective for the treatment and control roundworm infection caused by Toxascaris leonina (adults).
Up to 98.6 percent effective treatment and control of whipworm infections caused by Trichuris vulpis (adults).
Safe and effective, when used topically as directed. For dogs and puppies over 7 weeks of age, weighing at least three pounds. For cats and kittens over 9 weeks of age, weighing at least three pounds.
Important Safety Information:
Like all topical animal health treatments, Advantage Multi for Dogs and Cats, is not to be given to dogs or cats orally, is not for human use, and should be kept out of the reach of children. Ingestion of this product by dogs may cause serious adverse reactions including depression, salivation, dilated pupils, incoordination, panting and generalized muscle tremors. In avermectin-sensitive dogs or cats, the signs may be more severe and may include coma and death. Reduce the risk of accidental oral ingestion by separating treated pets for 30 minutes. (see indications and warnings.) Children should not come in contact with the application sites for two hours after application.